Continuous glucose monitoring and metrics for clinical trials: an international consensus statement

Randomised controlled trials and other prospective clinical studies for novel medical interventions in people with diabetes have traditionally reported HbA1c as the measure of average blood glucose levels for the 3 months preceding the HbA1c test date. The use of this measure highlights the long-est...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The lancet. Diabetes & endocrinology 2023-01, Vol.11 (1), p.42-57
Hauptverfasser:	Battelino, Tadej, Alexander, Charles M, Amiel, Stephanie A, Arreaza-Rubin, Guillermo, Beck, Roy W, Bergenstal, Richard M, Buckingham, Bruce A, Carroll, James, Ceriello, Antonio, Chow, Elaine, Choudhary, Pratik, Close, Kelly, Danne, Thomas, Dutta, Sanjoy, Gabbay, Robert, Garg, Satish, Heverly, Julie, Hirsch, Irl B, Kader, Tina, Kenney, Julia, Kovatchev, Boris, Laffel, Lori, Maahs, David, Mathieu, Chantal, Mauricio, Dídac, Nimri, Revital, Nishimura, Rimei, Scharf, Mauro, Del Prato, Stefano, Renard, Eric, Rosenstock, Julio, Saboo, Banshi, Ueki, Kohjiro, Umpierrez, Guillermo E, Weinzimer, Stuart A, Phillip, Moshe
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Blood Glucose - analysis Blood Glucose Self-Monitoring Child Clinical Trials as Topic Diabetes Mellitus, Type 1 - drug therapy Endocrinology and metabolism Human health and pathology Humans Hyperglycemia - therapy Hypoglycemia - prevention & control Life Sciences Prospective Studies
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!